Printer Friendly
The Free Library
23,403,340 articles and books


New Hope For Breast Cancer Patients.

New Hope For Breast Cancer Patients

Major Independent Trial Demonstrates Anticancer Benefit of Zometa (Zoledronic Acid) in Women With Early Stage Breast Cancer;

When added to hormone therapy, following surgery, Zometa significantly reduced the risk of cancer returning or death by 36% beyond clinical benefits achieved with hormone therapy alone;

Findings May Allow UAE Doctors to Improve Standard of Care

A new independent trial presented at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) showed that Zometa[R] offered a significant anticancer benefit for premenopausal women with hormone-sensitive, early-stage breast cancer.

The study found that Zometa[R] when added to hormone therapy, following surgery, significantly reduced the risk of cancer returning or death by 36 percent beyond clinical benefits achieved with hormone therapy alone.

Zometa[R] is the treatment for prevention or delay of skeletal related events in patients with advanced bone tumors, slows the bone-destroying effect that occurs with bone metastases by fighting abnormal activation of the cells that normally break down old bone, and the cells that normally build new bone.

Zometa[R] has been shown to make passage through the stages of tumor growth more difficult by inhibiting angiogenesis (formation of blood vessels that grow and feed cancer cells), stimulating cancer-fighting T-cells, inducing tumor cell apoptosis (programmed cell death) and increasing the activity of anticancer agents that target tumor cell metastases.

"Early detection of breast cancer in conjunction with advanced treatments available today give women a significantly better chance of survival," said Dr. Farid Khalifa, Consultant Oncologist and Head of Oncology Department, Dubai Health Authority.

This study is the first large-scale trial to demonstrate the significant antitumor benefit of Zometa[R] and the findings may allow oncologists to further improve the standard of care for premenopausal women with hormone-sensitive early stage breast cancer.

Dr. Farid Khalifa, Consultant Oncologist and Head of Oncology Department, Dubai Health Authority, Dr. Falah Al Khatib, Gulf Cancer Center - UAE, and Dr. Salah Fayaz, consultant clinical oncologist and head of breast unit in Kuwait Cancer Center, attended ASCO which encourages worldwide collaboration on the latest cancer research and development of new cancer treatments.

[c] 2008 Al Bawaba (www.albawaba.com)
COPYRIGHT 2008 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Albawaba.com
Date:Jun 17, 2008
Words:361
Previous Article:LG finally reveals its Secret Digital leader's latest mobile handset takes Black Label series to its next level of innovation.
Next Article:Sweet Homes launches seven commercial and residential towers collectively valued at AED 1.3 billion.
Topics:



Related Articles
A new approach to breast cancer treatment.
HDC+BMT treatment option for breast cancer patients should continue to be evaluated, NCI researchers say.
AACR meeting unveils more good news in fight against 'women's cancers'.
Screen savers.
Mushrooms can help prevent breast cancer in older women: common white button mushrooms beneficial, even when cooked.
A new era for breast cancer therapy.
Triple-negative breast cancer: an update.
Life Extension Foundation sponsors highly promising breast cancer trial.
New Hope For Breast Cancer Patients.
Researchers study mushrooms' cancer fighting potential.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters